Analyst firms · Barclays · CNC

Barclays CNC price target and rating history

Centene Corporation (CNC) · Health Care

Barclays rates Centene Corporation (CNC) Overweight with a $54 price target, as of its latest action on Jan 5, 2026. It has published 5 rating actions on CNC since January 2022, including 1 upgrade and 1 downgrade. Across 6 firms with a CNC price target in the last 12 months, the median target is $65. Barclays's $54 is 17% below that.

Current rating
Overweight
Price target
$54
Median target, all firms
$65
Actions on CNC
5

Barclays price target on CNC

$107$81$542023202420252026
Barclays price target on CNC, each point a stated target, January 2022 to January 2026.

Every Barclays rating on CNC

How other firms rate CNC

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Argus ResearchBuy$80Aug 11, 2026
RBC Capital MarketsSector Perform$70Jun 23, 2026
Deutsche BankBuy$80May 20, 2026
Cantor FitzgeraldOverweight$60Apr 29, 2026
BofA SecuritiesBuy$60Apr 29, 2026
BarclaysOverweight$54Jan 5, 2026

Questions about Barclays and CNC

What is Barclays's price target for CNC?
Barclays's latest stated price target for Centene Corporation (CNC) is $54, from its action on Jan 5, 2026.
What is Barclays's rating on CNC?
Barclays rates CNC Overweight, a bullish rating, as of Jan 5, 2026.
When did Barclays last change its view on CNC?
On Jan 5, 2026, Barclays upgrades to Overweight from Equal Weight, price target $54.
How does Barclays's CNC target compare with other analysts?
Across 6 firms with a CNC price target in the last 12 months, the median target is $65. Barclays's $54 is 17% below that.

More CNC rating histories

All Barclays ratingsCNC news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.